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ABSTRACT
Hallervorden Spatz disease, also known as pantothenate kinase associated neuro-degeneration, is a rare, progressive
neurological disorder usually seen in first decade of life. It is associated with extrapyramidal effects, dysarthria and
dementia. Hallervorden Spatz Disease is also associated with psychiatric symptoms, depression and behavioral
changes. Affected patients are disabled predominantly by dystonia. MRI, in later stage of the disease, shows “eye of the
tiger’ appearance which is fairly diagnostic of Hallervorden Spatz Disease. Response to drugs is often poor and of limited
value to these patients. This report highlights a classical case of Hallervorden Spatz disease that presented as an outpatient with dystonia and psychotic symptoms and was diagnosed on the basis of clinical and radiological evidence.
CASE REPORT

physically and mentally healthy. He was born via a
full-term spontaneous vaginal delivery, with normal childhood milestones, fully vaccinated and no previous history
of hospitalization or any significant illness. On Examination, he had a blank facial expression. He had generalized dystonia, marked in right upper limb. He had burn
scars on his arm and neck. He had a tip-toe walk and
ataxic gait. His lower limb reflexes were brisk, MRI brain
showed bilateral basal ganglia hypodensities with
centrally placed area of hyperdensity, also known as the
“eye of the tiger’ appearance, mostly seen in patients
with Hallervorden Spatz disease. His further investigations included those needed to rule out Wilson’s disease,
ceruloplasmin, copper, ferritin; Vitamin B12 levels and
amino acid chromatography were within normal range.
(Table1) His ophthalmological examination done for
Kayser – Fleischer ring and retinitis pigmentosa was
normal. His peripheral film was unremarkable. His blood
iron levels were slightly decreased and his post exercise
lactic acid was elevated at 1:4 ratios.

A 9 years old boy, with no previous significant medical
history, presented to Neurology as an outpatient on 20th
February 2014 with a 3 years history of abnormal movements of all limbs and trunk, ataxic gait, cognitive impairment and psychomotor agitation. Three years back, he
was perfectly healthy, both mentally and physically,
studying in second grade. At the age of six, his family
noticed behavioral changes including hyperphagia,
general irritability and impulsiveness, irrelevant talk,
muttering to himself and occasional episodes of aggressiveness. He had once burnt himself and at another
occasion put his hand in the blender. After few months,
he developed abnormal movements first noticed in the
lower limb which gradually progressed to the rest of the
body. There was no preceding history of fever, use of any
drugs, jaundice, incontinence, seizures or any focal
deficit. He is the youngest, born to first degree consanguineous parents. He has 13 siblings, all of whom are
Table 1: Pertinent Investigations
Tests
Serum Iron levels
Vitamin B12 levels
Ceruloplasmin levels
Copper Serum

Results
31 μg/dL
47.4 pmol/L
23 mg/dL
103.02 ug/dL
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Reference Range
Male 65-175 μg/dL
25-165pmol/L
20-60 mg/dL
Children(6 Years) 90-190 ug/dL
Children(12 Years) 80-160 ug/dL
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Lactic Acid (pre-exercise)
Lactic Acid (post exercise)
Ferritin levels
Amino acid
Chromatography

10.9mg/dL
45.1mg/dL

4.5-19.8 mg/dL

101.71ng/mL

Male 22.0-275.0 ng/mL
Female 5.0-204.0 ng/mL
Unremarkable

Unremarkable

He was diagnosed as Hallervorden Spatz disease. The
family was counselled about the progression and prognosis of the disease. He was given a trial of Trihexiphenidyl, clonazepam and baclofen. The patient on follow up
was neurologically the same but dystonia had improved
slightly.
DISCUSSION
Hallervorden Spatz disease is an autosomal recessive
disease, first described by Julius Hallervorden and Hugo
Spatz in 1922 (1). In most cases, defect lies in the gene
coding for pantothenate kinase 2 (PANK2) located on
chromosome 20p13-p12.3 (2). This gene causes iron
storage in brain, which in the presence of oxygen,
causes degeneration of the nervous system (3). However,
in 15% of people it may be sporadic (4).One of the limitations of the case is that we were unable to do genetic

studies due to limited resources.
The symptoms of Hallervorden Spatz Disease are usually
found between 7-15 years of age. The disease has also
been reported in infancy and adults (5, 6). Very few cases of
this disease have been reported in Pakistan (7). The
diagnostic criteria for HSD consist of three obligate, two or
more collaborate and none of the exclusion features, as
shown in table 2.
CT scan findings are non specific. MRI in early stage of
the disease may be normal, later, however, it may be
helpful in diagnosis. MRI shows bilateral symmetrical
hyperintense signal changes in anterior globus pallidus
with a surrounding hypointensity as shown in Figure 1.
The hypointensity is due to loss of signals secondary to
iron deposition and hyperintensity is a result of various
pathological changes including axonal swelling and
demyelination. These imaging features are fairly
diagnostic of HSD 8.

Table 2: Diagnostic Features (3)

Obligate Features

Onset during first two decades
of life
Progressive nature of the
disease

Extra-pyramidal dysfunction

Collaborate Features

Pyramidal tract signs

Progressive cognitive
impairment

seizures
Retinitis pigmentosa
Positive family history

Exclusion Features

Non progressive nature of the
disease
Family history positive for
Huntington’s disease, caudate
atrophy or autosomal
dominant movement disorder
Absence of extrapyramidal signs
Predominant epileptic episode
Abnormal ceruloplasmin or
copper level

Hypodensity in basal ganglia
on MRI brain
Abnormal cytoplasm in
lymphocytes
Sea blue histocytes on bone
marrow
There is no known cure for this disease. Hence the treatment is mainly directed towards managing symptoms of
the patient. Studies suggest safety of desferrioxamine as
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chelating agents for iron accumulation in the brain, but
there has been no study so far proving its beneficial role
(9)
. Anti-Parkinson’s drugs including levodopa, bromocrip
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Figure 1: MRI Brain (a) Coronal T2 W image (b) axial
FLAIR image showing bilateral symmetrical hyperintense
signal changes in anterior globus pallidus with a
surrounding hypointensity.
Fig 1 (a)

2.
3.

Fig 1 (b)
4.
5.

6.

7.

tine and anticholinergics, have been used for extrapyramidal effects in patients. Baclofen has also been used
for dystonia and has been of limited benefit to these
patients. Use of conventional antipsychotics for psychiatric symptoms has not been recommended, however,
there are studies on efficacy of clozapine and atypical
antipsychotics (10).

8.

CONCLUSION

9.

Unfortunately, there is limited literature on Hallervorden
Spatz disease and more studies need to be done for full
understanding of the disease and management.
Because the disease is rare, reporting such cases would
benefit the practicing neurologist to be familiarized with
this rare disease.
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